K-V Gets FDA To Test Adequacy Of Makena’s Competing Compounded Products

Compounded hydroxyprogesterone caproate and their APIs show they vary in potency and purity, K-V Pharmaceutical says; FDA is conducting its own analysis.

More from Archive

More from Pink Sheet